Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans (Q46925293)

26 December 2017

title

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans (English)

1 reference

26 December 2017

author name string

Nobuaki Ito

1

1 reference

26 December 2017

Seiji Fukumoto

2

1 reference

26 December 2017

Yasuhiro Takeuchi

3

1 reference

26 December 2017

Shu Takeda

4

1 reference

26 December 2017

Hisanori Suzuki

5

1 reference

26 December 2017

Takeyoshi Yamashita

6

1 reference

26 December 2017

Toshiro Fujita

7

1 reference

26 December 2017

publication date

25 October 2007

1 reference

26 December 2017

Journal of Bone and Mineral Metabolism

published in

1 reference

26 December 2017

volume

25

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

419-422

1 reference

26 December 2017

A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis

cites work

1 reference

12 December 2020

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

12 December 2020

Serum FGF23 levels in normal and disordered phosphorus homeostasis

1 reference

12 December 2020

FGF-23 is elevated by chronic hyperphosphatemia

1 reference

12 December 2020

Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia

1 reference

12 December 2020

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

1 reference

12 December 2020

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

12 December 2020

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

1 reference

12 December 2020

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

12 December 2020

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

1 reference

12 December 2020

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

1 reference

12 December 2020

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

12 December 2020

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

1 reference

12 December 2020

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

12 December 2020

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

12 December 2020

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

1 reference

12 December 2020

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

1 reference

12 December 2020

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

1 reference

12 December 2020

A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

1 reference

12 December 2020

FGF-23 in patients with end-stage renal disease on hemodialysis

1 reference

12 December 2020

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

12 December 2020

10.1007/S00774-007-0779-3

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017